Browsing Category
Bio space
1612 posts
Ashion Analytics to Present Data on the Value of Comprehensive Genomic Profiling of Gastrointestinal Cancers by Utilizing the GEM ExTra® Test
Ashion Analytics LLC, a CLIA-certified and CAP-accredited clinical laboratory announced that they will present data at the 2021…
Phase 2 FIGHT Trial Results Presented at ASCO GI Validate Importance of FGFR2b Overexpression and Reinforce Potential of Bemarituzumab Plus Chemotherapy as a Frontline Targeted Treatment for FGFR2b+ Gastric and GEJ Cancers
All three efficacy endpoints (PFS, OS and ORR) in the FIGHT Phase 2 trial met pre-specified statistical significance…
Syntekabio Signs Joint Development Agreement with Hanmi Science
Syntekabio (KOSDAQ: 226330), an AI and NGS-based drug development company, announced that it has signed multiple co-development agreement…
Agenda for Calliditas virtual R&D Day on January 20, 2021
Calliditas Therapeutics AB announced the program for the upcoming virtual R&D Day for investors, analysts and journalists on…
Lilly Announces $30 Million Limited Partner Investment in Unseen Capital Health Fund
Fund will provide support for minority-owned early-stage healthcare companies and is a component of Lilly’s racial justice efforts…
Dr. Reddy’s Receives Approval to Conduct Phase 3 Clinical Trial for Sputnik V Vaccine in India
Dr. Reddy’s Laboratories Ltd (BSE: 500124, NSE: DRREDDY, NYSE: RDY, NSEIFSC: DRREDDY) announced today that it has received…
Eurofins launches new tests and massive capacity for detecting and monitoring new variants of SARS-CoV-2
The increasing diversity of SARS-CoV-2 variants and the potential higher infectivity of some new viral strains, underline the…
Parkinson’s Disease and Latent (Hidden) Viruses. CBCD Reports an Important Discovery on the Cause of the Disease
The discovery was made possible by using the microcompetition model created by Dr. Hanan Polansky [15-January-2021] …
ACEP Applauds Removal of X-waiver, Expanding Medication-assisted Treatment for Opioid Use Disorder
The American College of Emergency Physicians applauds the U.S. Department of Health and Human Services’ decision to effectively…
Zanidatamab Data Highlight Durable Antitumor Activity in HER2‑Expressing Biliary Tract and Gastroesophageal Cancers at ASCO Gastrointestinal Cancers Symposium
Durable Responses Observed in Refractory Biliary Tract Cancer (BTC) and Gastroesophageal (GEA) Cancers Enrollment Continues for Zanidatamab Global…
